Noida-based pharma Marion Biotech has come under a cloud as reports of children dying after consuming cough syrup made here came in from Uzbekistan. The matter is under investigation.
This Ayushman Bharat Digital Mission-compliant solution is envisioned to provide a digital platform to health care providers, particularly focusing on private clinics and small health facilities, according to the ministry of health and family welfare. Hospital management information system i
Union Health Minister Mansukh Mandaviya on Friday said that all the manufacturing activities of the Noida-based pharma company have been stopped in view of the reports of contamination in cough syrup Dok1 Max.
The India-Australia Economic Cooperation and Trade Agreement (Ind-Aus ECTA) will benefit Indian exports from preferential duty market access in Australia and will benefit India's labor-intensive sectors such as gems and jewelry, textiles, leather, footwear, furniture, food and agricultural p
Union Health Minister Dr Mansukh Mandaviya on Thursday chaired a with drug manufacturing pharma companies for advance preparedness for Covid-19 management, as per official sources
This comes as India is in contact with the national drug regulator of Uzbekistan regarding reports of Noida-based cough syrups allegedly linked to the deaths of 18 children in Uzbekistan. The health ministry said that there have been reports from Uzbekistan concerning contaminated cough s
"We regret the deaths of children in Uzbekistan. The Central government is conducting an inquiry and we will take an action as per their report. They have taken samples of the medicine," legal representative of Marion Biotech Pharma Company, Hasan Harris said. The deaths of Uzbekistan chi
The death of 18 children in Uzbekistan allegedly after having cough syrup manufactured by an Indian pharmaceutical firm, has turned into a political row on Thursday after the Congress said that the Modi government should stop boasting about India being a pharmacy to the world.
After Uzbeskistan reported the death of 18 children from an acute respiratory distress allegedly after having a cough syrup manufactured by an Indian pharmaceutical firm, sources in the Central Drugs Standard Control Organisation (CDSCO) said it will investigate the claim.
As many as 18 children died of acute respiratory disease after having a cough syrup manufactured by an Indian pharmaceutical firm named Doc-Max, the Health ministry of Uzbeskistan has claimed.